PulseCath BV

💡We are ready for day 2 at the Interventional Cardiology Congress CITICmx in Mexico City. 👉 Want to learn more about iVAC 2L, pulsatile percutaneous ventricular assist device, for protected high-risk PCI? Please visit our booth for a simulator demonstration and the latest clinical insights. The team ALEJANDRO GARZA, Alexis Moncada Briones, Gerardo Moreno, Chrisna De Wet is looking forward to meeting you. Thank you to our partner ARF Medical. #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

⚡️Exciting news in Mexico  🔎 Together with our partner ARF Medical, director ALEJANDRO GARZA, Alexis Moncada Briones and Gerardo Moreno we are exhibiting the Interventional Cardiology Congress CITICmx in Mexico City, 26-28 June 2024. 💡Special highlight today in the session “PCI in Unstable patients” at 23:45 CEST: 🎤 Percutaneous pulsatile left ventricular support and transcatheter edge-to-edge mitral valve repair by Dr. Gioel Gabrio Secco, Ospedale Civile Ss. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. 👉 If you would like to join online: https://lnkd.in/e8FhynuM 🚩 Want to learn more about iVAC 2L, pulsatile percutaneous ventricular assist device, for protected high-risk PCI? Our Clinical & Sales Support Manager, Chrisna De Wet is at your disposal at the booth with a demo and beating heart model. #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

📢 Last weekend PulseCath closed a great CSI Frankfurt again. There was great interest, discussions and contacts. Some highligths: 🎤 4 iVAC 2L case presentations: 👉   Transcatheter edge-to-edge mitral valve repair with percutaneous pulsatile left ventricular support: rationale, background and a clinical case – Dr. Edoardo Elia 👉  The use of a pneumatic-pulsatile percutaneous left ventricular assist device for short-term mechanical circulatory support: real-life experience and performance insights on short-term clinical endpoints – Dr. Ota Hlinomaz 👉  Temporary LV support device to support very high risk LM PCI and TAVI via axillary access - Dr. Matthew Mercieca Balbi 👉 PulseCath iVAC 2L use to support unstable VT ablation - Dr. Matthew Mercieca Balbi 🤝 Thanks to everyone who joined us to discover and learn more about iVAC 2L, pulsatile percutaneous ventricular assist device and complex High-Risk PCI. We embrace this exciting journey and near future. Do you like to know more about PulseCath? Please visit https://www.pulsecath.com/ Oren Malchin uwe p. kasten Helena Podrzaj Maja Krizaj Chrisna De Wet Marleen van Mastwijk #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

📢This week PulseCath will be exhibiting at the CSI Frankfurt Congress in Germany. Our team will be at Booth 24, ready to demonstrate iVAC 2L – pVAD �� Percutaneous Ventricular Assist Device - for protected high-risk PCI. Our experts are at your disposal with a simulator. See you in Frankfurt? 📅 Please join us for the sessions with iVAC 2L: 👉 Wednesday, 19 June: 12:00 Transcatheter edge-to-edge mitral valve repair with percutaneous pulsatile left ventricular support: rationale, background and a clinical case – Dr. Edoardo Elia 👉 Thursday, 20 June: 07:15 The use of a pneumatic-pulsatile percutaneous left ventricular assist device for short-term mechanical circulatory support: real-life experience and performance insights on short-term clinical endpoints – Dr. Ota Hlinomaz 12:35 Temporary LV support device to support very high risk LM PCI and TAVI via axillary access - Dr. Matthew Mercieca Balbi 👉 Saturday, 22 June: 08:00 PulseCath iVAC 2L use to support unstable VT ablation - Dr. Matthew Mercieca Balbi   #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI Helena Podrzaj Maja Krizaj uwe p. kasten Chrisna De Wet Oren Malchin

⚡️Another important milestone in Portugal 🏥 A new center started with the first successful complex high-risk PCI with the support of iVAC 2L, pulsatile percutaneous ventricular assist device. The protected PCI was performed by Dr Pedro Braga, Dr Gustavo Pires de Morais, Dr Daniel Caeiro Centro Hospitalar Gaia in Porto. 👨⚕️ Procedure: Urgent, ACS, male, 73 years old, DMII, Smoking/COPD, Dyslipidemia, Previous CABG, mild Aortic Regurgitation, last patent vessel, one stent deployed in bypass graft LAD. ACT target around 400, max. iVAC 2L flow 2.0 L/min. Femoral artery closed with double Perclose ProGlide closure device. 🤝 Congratulations and thank you Dr.  Pedro Braga  and the cathlabteam. Also big thanks to our partner Endovascular, Cesar Santos, Tiago Nicolau Eugenio Varela, maria lucia reis and  team. Chrisna De Wet Helena Podrzaj Maja Krizaj #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

📢 Exciting News: First Patient Enrolled in the UNLOAD CHIP trial at Radboudumc, Nijmegen, the Netherlands. 🏥 Prof. dr. Robert Jan van Geuns enrolled the first patient in the UNLOAD CHIP (Use of Mechanical Left Ventricular Unloading in Complex Higher-risk Indicated Procedures) trial in Radboudumc. It is a prospective, randomized, controlled, open-label, multicentre trial. The study aims to test whether the prophylactic use of PulseCath iVAC 2L during (stable) CHIP in patients with reduced LV function and concomitant left sided congestion is superior to a mechanical unassisted PCI procedure. The primary endpoint is all-cause mortality or cardiogenic shock after 30 days. Dr. Alex Nap is the Principal Investigator of the UNLOAD CHIP trial, Amsterdam VU Medical Center, the Netherlands. 🤝 Congratulations to the cathlab team and our Dutch partner KM Innovations Paul Wessels and Eelke Krijnen. Chrisna De Wet Oren Malchin #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

💡 We are thrilled to announce the successful Annual Convention & Scientific Session of the Taiwan Society of Cardiology in Taipei City, Tawain, last week. Special sessions with presentations about iVAC 2L: 👉 New Developments in Temporary Cardiac Support in High Risk PCI - Single Centre Experience from Malaysia by Prof. Azmee Mohd Ghazi from IJN Malaysia 👉 All you need to know about mechanical circulatory support by Prof. Jung Cheng Hsu from Far Eastern Memorial Hospital, Taiwan 🤝 We would like to thank the organization and the participation of many interventional cardiologists. Also big thanks to our strategic partner Huadong Medicine Co., Ltd and their local distributor in Taiwan, WinChamp Medical Co., Ltd, Director Mr. Louie Ku and team Chu Yu Yin, Hsieh Chih Yuan, Huang Sheng Lin, Huang Yi Zhen, Lee Hui Ping, Lee Tsung Yin, Lin Hung Sheng, Lin Yi Ting, Li Wing Yi, Lo Yi Yen. Doris Xu Oren Malchin 🔎 Want to learn more about iVAC 2L, pulsatile percutaneous ventricular assist device, for protected high-risk PCI? Visit www.pulsecath.com or book a demo. #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI 

⚡️PulseCath expands in Asia-Pacific (APAC) region.⚡️In Hong Kong the first successful Complex High Risk and Indicated (CHIP) PCI case with the support of iVAC 2L, pulsatile percutaneous ventricular assist device, was performed by Dr. Chan Yu Ho in CUHK Medical Centre and Dr. Lam Yat Yin (Hong Kong Asia Heart Centre).  👨⚕️Patient male, 71 years old, Hypertension, Dyslipidemia, Previous PCI, EF 30%. Unprotected LM and 3-vessel disease. LM, LAD and LCx were managed with PCI. Total iVAC 2L support time was 90 minutes. The patient was hemodynamically stable during the PCI, especially when performing Balloon Angioplasty to LM. Femoral artery was closed with MANTA vascular closure device. 🤝 Congratulations to Dr. Chan Yu Ho, Dr. Lam Yat Yin and CUHK Medical Center Cath lab team for this huge milestone. Big thanks to our strategic partner Huadong Medicine Co., Ltd and their local distributor in Hong Kong Prism Technologies Limited Raymond Chan, Sammy Sheung, Doris Xu, Helen Lu, Wesley Zhang, Oren Malchin #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

⚡️About this week in Spain⚡️The ACCIS meeting hosted by Dr. Ignacio Amat, Head of the Interventional Cardiology department, Dr. Alberto Campo, Dr. Clara Fernández Cordón and team took place in University hospital Valladolid. This meeting has been created to review and discuss the latest controversies and advances in this exciting field by putting together annually all the stakeholders. Advanced heart failure and cardiogenic shock require coordinated implementation of critical care, mechanical circulatory support and imaging-guided electrical, coronary and structural interventions. 💡 Special highlight: Interactive Workshop iVAC 2L, pulsatile percutaneous ventricular assist device led by registered cath lab nurses: Nerea González Díez and Silvia Fernández Garrido and product demonstration by our clinical & sales support manager Helena Podrzaj. Eugenio Varela Cesar Santos Tiago Nicolau Thank you all for joining and big thanks for the organization. Would you like to know more about iVAC 2L and protected High-Risk PCI? 👉 pulsecath.com #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI

🙌 In Slovakia another successful complex high-risk PCI with the support of iVAC 2L, pulsatile percutaneous ventricular assist device was performed by Dr. Ota Hlinomaz in Bratislava. 👉 Procedure: elective, patient 63 years old, NYHA class III, EF 40%. 3-vessel disease, RCA 90% occluded. Vessels to treated were LM, LAD, Intermediate Branch, 3 stents deployed. IVUS guided PCI, iVAC 2L support time 90 minutes, max. iVAC 2L flow 1,2 L/min, highest ACT 450. Femoral artery closed with double Perclose ProGlide closure device. 🌟Congratulations and thank you to Dr. Ota Hlinomaz and cathlabteam. This hospital is Center of Excellence for PulseCath iVAC 2L. We are grateful for the long-standing and trustful cooperation in the field of short-term Mechanical Circulatory Support, also big thanks to our partner GlobalMed, Michal Rzounek, Jozef Kubela and team. Helena Podrzaj #PulseCath #iVAC2L #MCS #pVAD #interventionalcardiology #medicaldevices #healthcareinnovation #protectedPCI